Delivery Order SPE2DX22D0049-SPE2D825FB0PL
- Not listed
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,140.36 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a competitive, non-set-aside procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $5,739.90 to AmerisourceBergen Drug Corp on August 11, 2025, with a completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $118,601.30 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order was competitively awarded without a set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,983.12 to AmerisourceBergen Drug Corp on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contractor,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $56,394.30 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $51,451.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract (CAGE 0U9U0) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $13,650.00 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, with completion scheduled for August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime pharmaceutical distributor, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FB0PLDelivery Order
The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $10,316.76 to AmerisourceBergen Drug Corp on September 1, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 through December 2026. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor supplying critical medical products to federal healthcare systems serving military personnel, veterans, and other government health programs. This delivery order exemplifies AmerisourceBergen's role as a primary pharmaceutical vendor within the DLA's global medical supply network. The company supplies a comprehensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm fixed-price contract structure and the relatively short completion timeline reflect typical pharmaceutical supply delivery operations. AmerisourceBergen's demonstrated capability to compete successfully for federal medical procurement—as evidenced by numerous competitively awarded contracts ranging from small-value transactions to orders exceeding $45,000—underscores its significance as a critical vendor supporting U.S. military and federal healthcare logistics infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 9/1/25 |